Referenties 1. Bille K, Figueiras D, Schamasch P, Kappenberger L, Brenner JI, Meijboom FJ, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehabil. 2006;13(6):859-875. 2. http://www.sportcor.nl/. 3. Drezner JA, Ackerman MJ, Cannon BC, Corrado D, Heidbuchel H, Prutkin JM, et al. Abnormal electrocardiographic findings in athletes: recognizing changes suggestive of primary electrical disease. Br J Sports Med. 2013;47(3):153-167. 4. Benito B, Brugada J, Brugada R, Brugada P. Brugada Syndrome. Rev Esp Cardiol. 2009;62(11):1297-1315. 5. Adries E, Stroobandt R, Cock De N, Sinnaeve F, Verdonck F. ECG UIT of IN het hoofd. Antwerpen/Apeldoorn: Garant; 2006. p 363-377. 6. Jellins J, Milanovic M, Taitz DJ, Wan SH, Yam PW. Brugada syndrome (review article). Hong Kong Med J 2013;19:159-167. 7. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270-1279. 8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace. 2006;8(9):746-837. 9. Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6(9):1335-1341. 10. Cismaru G, Brembilla-Perrot B, Pauriah M, Zinzius PY, Sellal JM, Schwartz J, et al. Cycle length characteristics differentiating non-sustained from self-terminating ventricular fibrillation in Brugada syndrome. Europace. 2013;15(9):13131318. 11. Heidbüchel H, Corrado D, Biffi A, Hoffmann E, PanhuyzenGoedkoop N, Hoogsteen J et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil. 2006;13(5):676-686. 12. Maron BJ, Chaitman BR, Ackerman MJ, Bayés de Luna A, Corrado D, Crosson JE, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807-2816. 13. McArdle WD, Katch FI, Katch VL. Exercise Physiology. Energy, nutrition and human performance. Baltimore/Philadelphia: Lippincott Williams & Wilkins; 2007. p 637-665. 14. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J. 2005;26:1422-1445. Over de auteurs Drs. Shanna Ilbrink, AIOS sportgeneeskunde, Universitair Medisch Centrum Groningen. Drs. Shanna Ilbrink was als sportarts in opleiding werkzaam op de afdeling cardiologie van het Martini Ziekenhuis te Groningen. Dr. Robert G. Tieleman, cardioloog, Martini Ziekenhuis. Dr. Robert Tieleman is als cardioloog werkzaam in het Martini Ziekenhuis te Groningen. Eén van zijn aandachtsgebieden is de behandeling van ritmestoornissen. Corresponderende auteur: Shanna Ilbrink Sportmedisch Centrum UMCG Hanzeplein 1 9700 RB Groningen Triade gebouw 23 Tel: 050-361 77 00 Fax: 050-361 77 17 E-mail adres: s.ilbrink@umcg.nl nummer 5 | november 2014 | Sport & Geneeskunde 21 Pagina 20
Pagina 22Scoor meer met een online shop in uw vakbladen. Velen gingen u voor en publiceerden publicaties online.
Sport & Geneeskunde nummer 5 | november 2014 Lees publicatie 42Home